Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30150% above fair value
$26.35−1.45 (-5.22%)
Close on Nov 12, 2026Market cap $1.01BP/E –Yield –
Ceribell enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Ceribell's enterprise value was $953.29M on Nov 11, 2026, against $479.96M a year earlier. Over the last 2 years it ranged from $108.27M to $953.29M, with a median of $547.61M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $953.29M | +43.6% |
| 2025 | Dec 31, 2025 | $663.72M | +328.3% |
| 2024 | Dec 31, 2024 | $154.95M | – |
See a number that looks wrong?